Skip to content

Metabolomics of prostate cancer patients to identify diagnostic and prognostic biomarkers

An investigation into metabolomics of prostate cancer patients to identify diagnostic and prognostic biomarkers for disease burden and therapeutic outcome, and development of metabolomics database

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/048921
Enrollment
300
Registered
2023-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C61- Malignant neoplasm of prostate

Interventions

None listed

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients aged >= 18 years 2) Prostate cancer Any T, any N, M0 or M1

Exclusion criteria

Exclusion criteria: 1. Patients who are not willing to participate and will not provide signed informed consent 2. Patients with metabolic disorders 3. Thyrotoxicosis patients 4. Patients with uncontrolled DM, defined as HbA1c >=7.5% 5. Patients with hepatic dysfunction that is those in whom serum bilirubin will be more than 1.5 and, AST and ALT will be more than 2.5 fold higher than the upper limit of normal at baseline 6. Patients in whom serum creatinine will be more than 1.5 fold higher than the upper limit of normal

Design outcomes

Primary

MeasureTime frame
(1) To compare the differences in metabolites in blood samples of patients a) With bone metastasis (high grade) b) Without bone metastasis (low grade) (2) To identify differences in metabolites in blood samples of a) ADT responders or CSPC b) ADT non responders or CRPC Comparison will be made with healthy age matched male individuals (3) To create a metabolomics database for prostate cancer Timepoint: at Baseline: at the time of recruitment of the patient in the study in different groups

Secondary

MeasureTime frame
N/ATimepoint: N/A

Countries

India

Contacts

Public ContactDr Amlesh Seth

All India Institute of Medical Sciences

amlesh.seth@gmail.com011-26594884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026